Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,715,985
+$2,298,584 QoQ
Shares Held
18,741
+68.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.97%
of 13F equity value
Holder Rank
#1,348
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carolina Wealth Advisors, LLC holds $23,609,987 across 8 Drug Manufacturers - General names. ABBV ranks #1 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
18,741 | $4,715,985 | |
| 2 | AMGN |
Amgen Inc
|
13,010 | $4,711,181 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,171 | $4,133,973 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
56,312 | $3,244,697 | |
| 5 | NVO |
Novo Nordisk A S
|
52,148 | $2,499,975 | |
| 6 | JNJ |
Johnson & Johnson
|
8,728 | $2,216,650 | |
| 7 | LLY |
ELI LILLY & Co
|
1,724 | $2,067,817 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
156 | $19,709 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,715,985 | 18,741 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,417,401 | 11,115 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $138,236 | 605 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $143,554 | 620 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $7,218,204 | 38,887 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $8,038,653 | 38,367 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $6,917,150 | 38,926 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $7,816,258 | 39,580 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $7,106,073 | 41,430 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $7,364,670 | 40,443 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $6,611,950 | 42,666 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,367,545 | 42,718 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $5,542,253 | 41,136 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $6,512,176 | 40,862 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $6,553,285 | 40,550 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $5,481,539 | 40,843 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,180,924 | 40,356 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $6,432,524 | 39,680 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $5,197,464 | 38,386 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $4,368,519 | 40,498 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $4,484,536 | 39,813 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,186,057 | 38,681 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $4,678,276 | 43,661 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $4,094,744 | 46,749 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,508,818 | 45,924 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $3,401,731 | 44,648 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||